Inactive Instrument

Highlights MANA CAPI

Equities

MAAQ

US56168P1049

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Mana Capital Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-07	CI
MANA CAPI : UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION - Form 8-K	22-10-31	PU
Mana Capital, Cardio Diagnostics Complete Merger	22-10-26	MT
Cardio Diagnostics Inc. completed the acquisition of Mana Capital Acquisition Corp. from a group of shareholders in a reverse merger transaction.	22-10-24	CI
Mana Capital Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-10	CI
Mana Capital Acquisition : and Cardio Diagnostics, Inc. Announce Definitive Business Combination Agreement to Create Publicly Listed Company Set to Transform Cardiovascular Disease Through Epigenetics - Form 8-K	22-05-31	PU
Cardio Diagnostics to Go Public Through Merger With Mana Capital Acquisition	22-05-31	MT
Mana Capital Acquisition Corp. and Cardio Diagnostics, Inc. Announce Definitive Business Combination Agreement to Create Publicly Listed Company Set to Transform Cardiovascular Disease Through Epigenetics	22-05-31	BU
Cardio Diagnostics Inc. entered into a definitive business combination agreement to acquire Mana Capital Acquisition Corp. from a group of shareholders for approximately $110 million in a reverse merger transaction.	22-05-30	CI
Mana Capital Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-12	CI
Mana Capital Acquisition Corp. Reports Earnings Results for the Seven Months Ended December 31, 2021	22-03-31	CI
Mana Capital Acquisition Corp. has completed an IPO in the amount of $62 million.	21-11-22	CI
Mana Capital Acquisition Corp. has filed an IPO in the amount of $60 million.	21-10-19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer